Amgen Common Stock Total Equity from 2010 to 2024
AMGN Stock | USD 306.50 2.91 0.94% |
Common Stock Total Equity | First Reported 1999-09-30 | Previous Quarter 32.5 B | Current Value 32.6 B | Quarterly Volatility 9.1 B |
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.3 B, Interest Expense of 3 B or Selling General Administrative of 5.8 B, as well as many exotic indicators such as Price To Sales Ratio of 9.47, Dividend Yield of 0.0185 or PTB Ratio of 25.96. Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
Amgen | Common Stock Total Equity |
Latest Amgen's Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of Amgen Inc over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Amgen's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
Timeline |
Amgen Common Stock Total Equity Regression Statistics
Arithmetic Mean | 29,039,889,250 | |
Geometric Mean | 25,792,660,429 | |
Coefficient Of Variation | 26.90 | |
Mean Deviation | 4,021,923,867 | |
Median | 30,784,000,000 | |
Standard Deviation | 7,812,862,473 | |
Sample Variance | 61040820T | |
Range | 35.3B | |
R-Value | 0.54 | |
Mean Square Error | 46585087.9T | |
R-Squared | 0.29 | |
Significance | 0.04 | |
Slope | 942,953,826 | |
Total Sum of Squares | 854571480.2T |
Amgen Common Stock Total Equity History
About Amgen Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Amgen income statement, its balance sheet, and the statement of cash flows. Amgen investors use historical funamental indicators, such as Amgen's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Amgen investors may use each financial statement separately, they are all related. The changes in Amgen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amgen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Amgen Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Amgen. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Common Stock Total Equity | 37.4 B | 27.1 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Amgen Correlation against competitors. Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.52) | Dividend Share 8.64 | Earnings Share 6.99 | Revenue Per Share 55.148 | Quarterly Revenue Growth 0.22 |
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.